Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonalcoholic Steatohepatitis (NASH) With Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Testing effectiveness (Phase 2)Looking for participantsNCT06588699
What this trial is testing

Digoxin In NASH (CODIN)

Who this might be right for
NASHNAFLDMASH - Metabolic Dysfunction-Associated Steatohepatitis+5 more
Yale University 144
Testing effectiveness (Phase 2)Study completedNCT00063232
What this trial is testing

Treating Nonalcoholic Steatohepatitis (NASH) With Metformin

Who this might be right for
Hepatitis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 28
Large-scale testing (Phase 3)Ended earlyNCT02704403
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Genfit 2,157
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Study completedNCT00885313
What this trial is testing

Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Not applicableUnknownNCT05798702
What this trial is testing

Fibrosis Reduction in Non Alcoholic Steatohepatitis

Who this might be right for
NASH With FibrosisWeight LossBariatric Surgery Candidate
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableLooking for participantsNCT03025074
What this trial is testing

Blood Collection Biorepository for Liver Disease Research

Who this might be right for
Non-Alcoholic Steatohepatitis(NASH)Hepatitis CHepatitis B+5 more
State University of New York at Buffalo 1,000
Not applicableActive Not RecruitingNCT04820036
What this trial is testing

A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)Endoscopic Sleeve GastroplastyNon-alcoholic Fatty Liver Disease (NAFLD)+4 more
Brigham and Women's Hospital 20
Not applicableStudy completedNCT02044523
What this trial is testing

Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound

Who this might be right for
Hepatitis CHepatitis BNonalcoholic Fatty Liver Disease (NAFLD)+1 more
Centre hospitalier de l'Université de Montréal (CHUM) 108
Testing effectiveness (Phase 2)Study completedNCT04173065
What this trial is testing

Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Viking Therapeutics, Inc. 248
Large-scale testing (Phase 3)Study completedNCT01934777
What this trial is testing

Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis

Who this might be right for
Fatty LiverLiver FibrosisObesity+2 more
Bambino Gesù Hospital and Research Institute 60
Not applicableLooking for participantsNCT05974904
What this trial is testing

Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseHepatic SteatosisLiver Fibrosis
Chongqing Medical University 7,000
Testing effectiveness (Phase 2)UnknownNCT05402371
What this trial is testing

Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Fibrosis, LiverNAFLD
Hepion Pharmaceuticals, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT04771273
What this trial is testing

Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Boehringer Ingelheim 295
Testing effectiveness (Phase 2)Ended earlyNCT01672879
What this trial is testing

Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH

Who this might be right for
Liver Fibrosis Due to NASH
Gilead Sciences 259
Not applicableStudy completedNCT05073588
What this trial is testing

Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Institute of Liver and Biliary Sciences, India 39
Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Next Page